Newsfeeds - Spark Newswire

1 minute read

Clene’s COVID-19 Candidate Shows No Substantial Symptom Resolution In Phase 2 Trial

Today, 8:51 PM

Clene Inc (NASDAQ:CLNN) announced topline study results from its Phase 2 trial of CNM-ZnAg for non-hospitalized acutely symptomatic participants infected with…

CLNN

1 minute read

HC Wainwright & Co. Maintains Buy on Clene, Lowers Price Target to $15

By Benzinga Newsdesk

Today, 8:51 PM

HC Wainwright & Co. analyst Joseph Pantginis maintains Clene (NASDAQ:CLNN) with a Buy and lowers the price target from $16 to $15.

CLNN

6 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 8:51 PM

During Monday's session, 96 stocks hit new 52-week lows.

ACHV

23 minute read

News
Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 8:51 PM

On Monday, 413 companies reached new 52-week lows.

AAN

47 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 8:51 PM

On Tuesday, 838 companies hit new 52-week lows.

$APE

7 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 8:51 PM

Wednesday saw 127 companies set new 52-week lows.

ARTW

3 minute read

Why Vicinity Motor Is Trading Higher By Over 65%; Here Are 26 Stocks Moving Premarket

By Lisa Levin

Today, 8:51 PM

Gainers Vicinity Motor Corp. (NASDAQ: VEV) rose 65.4% to $1.72 in pre-market trading. Vicinity Motor started deliveries of the first Class 3 electric truck to roll off the assembly line in Canada.

ADEA

3 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 8:51 PM

On Tuesday, 44 companies hit new 52-week lows.

ADIL

1 minute read

Canaccord Genuity Maintains Buy on Clene, Lowers Price Target to $6

By Benzinga Newsdesk

Today, 8:51 PM

Canaccord Genuity analyst Sumant Kulkarni maintains Clene (NASDAQ:CLNN) with a Buy and lowers the price target from $10 to $6.

CLNN

5 minute read

Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:51 PM

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.

$APE